Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
University Hospital, Strasbourg, France |
---|---|
Information provided by: | University Hospital, Strasbourg, France |
ClinicalTrials.gov Identifier: | NCT00620490 |
osteolateral thoracotomy is a painful surgical procedure.Thoracic epidural analgesia (TEA) is usually considered as the "gold standard" for postoperative thoracic analgesia. Unfortunately, it's not always possible to realize it because of contraindications or because of technical failures.Analgesia using a paravertebral block is an alternative to the TEA : it provides an unilateral sensitive and sympathetic block using a catheter.In our study, the catheter will be placed by the thoracic surgeon at the end of the surgical procedure, under direct vision, to insure maximal security also on patients on antiplatelets agents, anticoagulants or with haemostasis disorders (the placement of the catheter by the anaesthetist with the loss of resistance technique is contraindicated in these cases).Patients will be randomized to receive either a continuous 48-hours infusion of ropivacaine 0,5% or saline serum in the control group.All patients are connected to a PCA pump with intravenous morphine and will receive paracetamol and nefopam.The visual analogic scale (VAS) at rest and on movement, total morphine consumption and side effects will be recorded during the first 48 hours after surgery. The aim of this study is to prove a decrease of pain at rest and on movement, a decrease of the cumulated total morphine dose consumption and a decrease of the side effects (nausea, vomiting, pruritus, sedation, bradypnea, urinary retention).
Condition | Intervention | Phase |
---|---|---|
Pain |
Drug: ropivacaine Other: nacl 0,9% |
Phase III |
Study Type: | Interventional |
Study Design: | Prevention, Randomized, Double Blind (Subject, Investigator), Placebo Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | Postoperative Analgesia After Thoracotomy Without Thoracic Epidural Analgesia : Paravertebral Analgesia With a Catheter Associated With Intravenous Morphine Patient-Controlled-Analgesia (Pca) |
Estimated Enrollment: | 60 |
Study Start Date: | March 2008 |
Estimated Study Completion Date: | February 2009 |
Primary Completion Date: | March 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Experimental
Ropivacaine 0.5% 0.1 ml/kg per hour
|
Drug: ropivacaine
Ropivacaine 0.5% 0.1 ml/kg per hour
|
2: Placebo Comparator |
Other: nacl 0,9%
saline 0.9% 0.1 ml/kg per hour
|
Ages Eligible for Study: | 18 Years to 80 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Olivier Helms, MD | 00333.88.11.61.35 | olivier.helms@chru-strasbourg.fr |
France | |
Service de Chirurgie Thoracique, Hôpitaux Universitaires | Recruiting |
Strasbourg, France | |
Contact: Olivier Helms, MD 00333.88.11.67.60 Olivier.Helms@chru-strasbourg.fr | |
Principal Investigator: Olivier Helms, MD | |
Sub-Investigator: Jean-Gustave Hentz, MD | |
Sub-Investigator: Jean-Marie Wilhm, MD | |
Sub-Investigator: Gilbert Massard, MD | |
Sub-Investigator: Nicola Santelmo, MD | |
Sub-Investigator: Mircea Vasilescu, MD |
Principal Investigator: | Olivier Helms, MD | Hôpitaux Universitaires de Strasbourg |
Responsible Party: | Hôpitaux Universitaires de Strasbourg ( Emmanuel Lavoué, Directeur adjoint de la recherche clinique et de l'innovation ) |
Study ID Numbers: | 4068 |
Study First Received: | February 7, 2008 |
Last Updated: | March 3, 2008 |
ClinicalTrials.gov Identifier: | NCT00620490 |
Health Authority: | France: Afssaps - French Health Products Safety Agency |
Epidural analgesia Contraindications Paravertebral nerve block analgesia ropivacaine |
Visual analogical scale Morphine Side effects Pain and thoracotomy |
Morphine Ropivacaine Pain |
Sensory System Agents Therapeutic Uses Physiological Effects of Drugs Anesthetics Central Nervous System Depressants Narcotics |
Peripheral Nervous System Agents Analgesics Central Nervous System Agents Anesthetics, Local Pharmacologic Actions Analgesics, Opioid |